Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae-Reference-Cited by-同舟云学术

Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae

Published:2018-08-07 Issue:11 Volume:73 Page:3170-3175
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Sousa Adrian¹²,Pérez-Rodríguez María Teresa¹²,Soto Adriana¹,Rodríguez Lorena¹,Pérez-Landeiro Antonio³,Martínez-Lamas Lucia⁴,Nodar Andrés¹²,Crespo Manuel¹²

Affiliation:

1. Infectious Diseases Unit-Internal Medicine Department, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain

2. Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), Hospital Álvaro Cunqueiro Bloque técnico, Estrada Clara Campoamor 341, Vigo (Pontevedra), Spain

3. Pharmacy Department, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain

4. Microbiology Department, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/11/3170/26144696/dky295.pdf

Reference23 articles.

1. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases;Munoz-Price;Lancet Infect Dis,2013

2. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections;Falagas;Emerg Infect Dis,2014

3. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination;Zhanel;Drugs,2013